Connor, Clark & Lunn Investment Management (CC&L)’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Sell |
97,594
-132,967
| -58% | -$5.11M | 0.01% | 665 |
|
|
2025
Q1 | $8.93M | Buy |
230,561
+23,187
| +11% | +$898K | 0.04% | 348 |
|
|
2024
Q4 | $7.01M | Sell |
207,374
-357,560
| -63% | -$12.1M | 0.03% | 399 |
|
|
2024
Q3 | $23.1M | Buy |
564,934
+456,319
| +420% | +$18.7M | 0.11% | 147 |
|
|
2024
Q2 | $4.18M | Buy |
+108,615
| New | +$4.18M | 0.02% | 463 |
|
|
2022
Q4 | – | Sell |
-845,924
| Closed | -$24.9M | – | 1302 |
|
|
2022
Q3 | $24.9M | Sell |
845,924
-286,074
| -25% | -$8.42M | 0.16% | 102 |
|
|
2022
Q2 | $49.3M | Buy |
+1,131,998
| New | +$49.3M | 0.3% | 57 |
|
|
2020
Q3 | – | Sell |
-808,172
| Closed | -$33M | – | 1003 |
|
|
2020
Q2 | $33M | Buy |
808,172
+191,022
| +31% | +$7.79M | 0.23% | 83 |
|
|
2020
Q1 | $23.4M | Buy |
+617,150
| New | +$23.4M | 0.21% | 91 |
|
|
2018
Q3 | – | Sell |
-23,500
| Closed | -$947K | – | 1010 |
|
|
2018
Q2 | $947K | Sell |
23,500
-329,012
| -93% | -$13.3M | 0.01% | 630 |
|
|
2018
Q1 | $13.8M | Sell |
352,512
-458,800
| -57% | -$17.9M | 0.08% | 171 |
|
|
2017
Q4 | $28.8M | Sell |
811,312
-284,383
| -26% | -$10.1M | 0.17% | 110 |
|
|
2017
Q3 | $44.5M | Buy |
1,095,695
+219,759
| +25% | +$8.92M | 0.27% | 68 |
|
|
2017
Q2 | $37.8M | Buy |
875,936
+233,336
| +36% | +$10.1M | 0.25% | 79 |
|
|
2017
Q1 | $27.1M | Buy |
642,600
+615,000
| +2,228% | +$25.9M | 0.18% | 100 |
|
|
2016
Q4 | $1.06M | Buy |
+27,600
| New | +$1.06M | 0.01% | 475 |
|
|
2014
Q3 | – | Sell |
-20,252
| Closed | -$1.15M | – | 558 |
|
|
2014
Q2 | $1.15M | Hold |
20,252
| – | – | 0.01% | 308 |
|
|
2014
Q1 | $1.19M | Sell |
20,252
-64,938
| -76% | -$3.83M | 0.01% | 355 |
|
|
2013
Q4 | $4.83M | Sell |
85,190
-3,400
| -4% | -$193K | 0.04% | 159 |
|
|
2013
Q3 | $4.57M | Buy |
+88,590
| New | +$4.57M | 0.04% | 117 |
|